All articles by GlobalData Healthcare

Can PD-1 checkpoint inhibition enhance the NMIBC standard of care?

Bladder cancer accounts for over 200,000 deaths every year globally, with non-muscle invasive bladder cancer (NMIBC) making up 75% of…
GLP-1 receptor agonists poised to redefine treatment paradigms beyond diabetes and obesity

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), once focused on treating diabetes and obesity, are now emerging as potential treatments for a…
Study explores interplay between air pollution, genes, and Parkinson’s disease

Although Parkinson’s disease (PD) poses a serious risk to the quality of life and well-being of those suffering from it,…
Ultra-processed food consumption risks early death in lower income groups

Ultra-processed foods (UPFs) are a dominant part of the global food industry. UPFs are energy-dense, nutritionally unbalanced foods that contain…
Imfinzi approval positions AstraZeneca at forefront of perioperative MIBC

The FDA has recently approved AstraZeneca’s Imfinzi (durvalumab) for perioperative use in cisplatin-eligible muscle-invasive bladder cancer (MIBC), based on the…

Finerenone continues to impress in diabetic kidney disease

In a recent study conducted by Sankar D Navaneethan and colleagues and published in the International Society of Nephrology, the…
ESCMID Global 2025: Initial ABI-5366 data supports monthly dosing for genital herpes

Early clinical and preclinical findings presented at the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference…
ESCMID Global 2025: Gepotidacin is non-inferior to leading gonorrhoea dual therapy

At the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria, Dr Janet Wilson…
WHO publishes first-ever guidelines for meningitis diagnosis and care

Meningitis is a life-threatening condition caused by a bacterial or viral infection. Meningitis is an infection of the protective membranes…
ESCMID Global 2025: Global access issues remain for long-acting HIV injectables

The impact of long-acting injectables (LAIs) for HIV was discussed at the 35th European Society of Clinical Microbiology and Infectious…